[1] Roman SA.Endocrine tumors:evaluation of the thyroid nodule.Curt Opin Oncol,2003,15(1):66-70.
[2] 张永学.核医学.北京:人民卫生出版社,2005.254-259.
[3] Maki K,Okumura Y,Sato S,et al.Quantitative evaluation by Tl-201 scintigraphy in the diagnosis of thyroid follicular nodules.Ann Nucl Med,2003,17(2):91-98.
[4] 余永利,于建芳,朱瑞森.半定量法201Tl双时相显像鉴别诊断甲状腺冷结节.核技术,2002,25(11):969-972.
[5] 冯国伟,杨忠毅,田伟家,管樑.99mTc-甲氧基异丁基异腈双时相核素显像对甲状腺结节良、恶性鉴别的价值探讨.内科理论与实践,2008,3(3):186-187.
[6] Küζük ON,Gultekin SS,Aras G,et al.Radioiodine whole-body scans,thyroglobulin levels,99mTc-MIBI scans and computed tomography:results in patients with lung metastases from differentiated thyroid cancer.Nucl Med Commun,2006,27(3):261-266.
[7] Hurtado-Lopez LM,Martinez-Duncker C.Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules.Eur J Nucl Med Mol Imaging,2007,34(10):1701-1703.
[8] Tamizu A,Okumura Y,Sato S,et al.The usefulness of serum thyroglobulin levels and T1-201 scintigraphy in differentiating between benign and malignant thyroid follicular lesions.Ann Nucl Med,2002,16(2):95-101.
[9] Hardoff R,Baron E,Sheinfeld M.Early and late lesion to nonlesion ratio of thallium-201 chloride uptake in the evaluation of cold thyroid nodules.J Nucl Med,1991,32(10):1873-1876.
[10] 丁明辉,张宝牛,刘炯,等.99mTc-MIBI和99mTc(V)-DMSA乳腺肿物显像的比较研究.山西医药杂志,2004,33(11):945-945.
[11] Ugur O,Kestakglu L,Guler N,et al.Comparison of 99mTc(V)-DMSA,201TI and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.Eur J Nucl Med,1996,23(10):1367-1371.
[12] 邓波,肖欢,陈小凤,等.99Tcm(V)-DMSA与99Tcm-MIBI亲肿瘤显像在诊断甲状腺髓样癌中的对比.同位素,2004,17(1):62-64.
[13] Bohuslavizki KH.Somatosatin receptor imaging:current status and future perspectives.J Nucl Med,2001,42(7):1057-1058.
[14] Behr TM,Gotthardt M,Barth A,et al.Imaging tumors with peptidebased radioligands.Q J Nucl Med.2001,45(2):189-200.
[15] 武凤玉,左书耀.放射性核素标记奥曲肽肿瘤受体显像研究进展.国外医学:肿瘤学分册,2005,32(10):760-763.
[16] 谢新立,韩星敏,阮翘,程兵,刘保平.99Tcm-HL91乏氧显像在甲状腺结节良恶性鉴别诊断中的应用.中华核医学杂志,2008,28(2):103-105.
[17] 谭建.核医学在甲状腺癌诊断和治疗中的应用.中国实用内科杂志,2007,27(17):1339-1342.
[18] Al-Nahhas A,Khan S,Goqbashian A,et al.Review.18F-FDG PET in the diagnosis and follow-up of thyroid malignancy.In Vivo,2008,22(1):109-114.
[19] Macapinlac HA.FDG-PET in head and neck,and thyroid cancer.Chang Gang Med J,2005,28(5):284-295.